EYE 1.85% 27.5¢ nova eye medical limited

Nova Eye Medical (EYE) News & Analyst Coverage

  1. 15,717 Posts.
    lightbulb Created with Sketch. 4038
    Thought I would start a new thread for news and analyst coverage, so as to keep it all in one spot. Let's keep this for sharing news only, and discussion can occur on the discussion forum. I suspect as this company moves more and more into the spotlight, we should get more and more news flow. To start, here is an analyst report released by MST Access. I will attach a screenshot of the first page, but the full report can be accessed via their website (need to make an account). Unlike the E&P report, this one was paid for by the company, but it still provides plenty of good, detailed analysis. Numbers are similar to those forecasted by E&P Financial in their report, which is reassuring. Consensus view for revenue in FY24 is high 20s to 30 million, and near break-even EBITDA next year (so unlikely to see a further cap raise). This view is likely informed by the significant expansion in productive capacity by the company, which has been informed by their own internal forecasts (as stated in the recent annual results).

    https://hotcopper.com.au/data/attachments/5579/5579385-1f03b8dd5c7090b6eb57b2e8d204da5f.jpg
    Link: Company - MST Marquee (mstaccess.com.au)
 
watchlist Created with Sketch. Add EYE (ASX) to my watchlist
(20min delay)
Last
27.5¢
Change
0.005(1.85%)
Mkt cap ! $62.92M
Open High Low Value Volume
27.5¢ 28.5¢ 27.5¢ $105.1K 377.2K

Buyers (Bids)

No. Vol. Price($)
1 99735 27.5¢
 

Sellers (Offers)

Price($) Vol. No.
28.0¢ 39325 2
View Market Depth
Last trade - 15.59pm 16/07/2024 (20 minute delay) ?
EYE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.